PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2025Frontiers in Cardiovascular Medicine2 citationsOpen Access

Mapping the research landscape of artificial hearts: identifying hotspots and frontiers through bibliometric analysis

View Full Paper
YPYufeng PengKPKou PengLLLuyao Li

Key Points

  • Artificial heart research shows a 13.9% annual growth in publications and a 260-fold increase in citations.
  • The USA leads in research output while China exhibits rapid advancement in artificial heart technologies.
  • Key innovations include magnetic levitation systems and biohybrid technologies, addressing hemocompatibility challenges.
  • Interdisciplinary collaboration is vital for optimizing biocompatibility and transitioning to long-term adaptive solutions.

Abstract

Background The rising prevalence of advanced heart failure and the shortage of donor hearts underscore the need for artificial hearts. Technological evolution from pneumatic to magnetically levitated systems has occurred, yet critical challenges persist in hemocompatibility, anticoagulation, and transcutaneous energy transmission systems. Methods We conducted a bibliometric analysis of 6,310 publications from the Web of Science Core Collection using CiteSpace, VOSviewer, and Bibliometrix. This study aimed to delineate research trends, collaboration patterns, and technological advancements in the artificial heart field. Results Global publications showed a 13.9% average annual growth, with citations surging 260-fold. The USA leads research output, with China demonstrating rapid growth. Research focus has shifted from ventricular assist devices towards artificial intelligence control strategies. Magnetic levitation continuous-flow total artificial hearts and soft TAHs emerge as key technological innovations. Frontier research includes biohybrid systems and transcutaneous wireless power transfer. Conclusion Artificial heart research displays a three-stage progression: clinical need-driven, technology integration, and intelligent innovation. Enhanced interdisciplinary collaboration is vital to address persistent challenges in biocompatibility optimization and personalized anticoagulation. This is crucial for transitioning the treatment paradigm from mechanical replacement towards physiologically adaptive, long-term solutions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Peng et al. (2025) studied this question.

synapsesocial.com/papers/68de84b65b556a9128e1b506https://doi.org/10.3389/fcvm.2025.1613605
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical outcomes of HeartMate 3 left ventricular assist device support with a Bridge to Transplant vs a Destination Therapy strategy: a single-centre retrospective cohort2024 · 4 citations
  2. 2Global Air Pollutant Phenanthrene and Arrhythmic Outcomes in a Mouse Model2023 · 14 citations
  3. 3A Bibliometric and Knowledge-Map Analysis of Macrophage Polarization in Atherosclerosis From 2001 to 20212022 · 81 citations
  4. 4THE SOLAR CELL SYSTEM FOR EXTENSION OF THE BATTERY RUN-TIME IN THE MOVING-ACTUATOR TYPE TOTAL ARTIFICIAL HEART1997 · 2 citations
  5. 5A numerical investigation to evaluate the washout of blood compartments in a total artificial heart2020 · 7 citations